Wird geladen...
Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort
PURPOSE: Although clopidogrel is the most widely used oral P2Y12 receptor antagonist, up to 10% of acute coronary syndrome patients treated with clopidogrel will experience a recurrent myocardial infarction and 2–3% will experience stent thrombosis within 1 year. The purpose of this research is to d...
Gespeichert in:
| Veröffentlicht in: | Pharmacogenomics |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6462835/ https://ncbi.nlm.nih.gov/pubmed/30520344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2018-0148 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|